CME Group (CME) valuation
CME Group P/E ratio history
CME Group trades at 24.9 times its earnings over the last twelve months and 23.3 times the earnings analysts expect over the next twelve.
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
CME Group valuation against its peers
| Company | Market value | P/E | Forward P/E |
|---|---|---|---|
| CME GroupCME | $109B | 24.9 | 23.3 |
| Intercontinental ExchangeICE | $94.8B | 23.0 | 19.3 |
| S&P GlobalSPGI | $138B | 27.7 | 23.7 |
| Moody'sMCO | $85.5B | 30.1 | 27.1 |
| Charles SchwabSCHW | $153B | 16.0 | 11.8 |
| Robinhood MarketsHOOD | $76.4B | 39.4 | 27.0 |
| NasdaqNDAQ | $59.4B | 29.0 | 23.1 |
| MSCIMSCI | $45.3B | 33.0 | 28.7 |
| Cboe Global MarketsCBOE | $35.1B | 23.9 | 22.5 |
| Peer median | 28.4 | 23.4 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: CME returns
No forecast, no recommendation. This page describes CME Group from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.